HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Defining the Outcome Markers and Therapeutic Role for Omalizumab in Treatment of Allergic Bronchopulmonary Aspergillosis.

AuthorsPaul A Greenberger
JournalThe journal of allergy and clinical immunology. In practice (J Allergy Clin Immunol Pract) Vol. 11 Issue 3 Pg. 906-907 (03 2023) ISSN: 2213-2201 [Electronic] United States
PMID36702248 (Publication Type: Editorial, Comment)
Chemical References
  • Omalizumab
  • Anti-Allergic Agents
  • Antibodies, Monoclonal, Humanized
Topics
  • Humans
  • Omalizumab (therapeutic use)
  • Aspergillosis, Allergic Bronchopulmonary (drug therapy)
  • Anti-Allergic Agents (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: